PMID- 10695778 OWN - NLM STAT- MEDLINE DCOM- 20000309 LR - 20181130 IS - 0125-1562 (Print) IS - 0125-1562 (Linking) VI - 30 IP - 1 DP - 1999 Mar TI - The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients. PG - 7-10 AB - Tumor necrosis factor-alpha (TNF-alpha) is an endogenous mediator of shock and inflammation including malaria. Many lines of evidence suggest that cytoadherence, the life-threatening pathology associated with complicated and cerebral malaria, results from the overproduction of TNF in response to malarial parasite. Quinine has been shown to inhibit TNF synthesis and cytoadherence in vitro suggesting an additional beneficial effect of quinine on its anti-TNF action. On the other hand, artesunate inhibits cytoadherence better than quinine does not suppress TNF production in vitro. The present study compares the effect of artesunate and quinine on TNF levels of malaria-infected patients. Surprisingly, plasma TNF levels increased dramatically after quinine administration but did not increase after artesunate administration. This difference may be explained by previous observations showing that artesunate kills parasites in vitro and clears parasitemias in vivo for more rapidly than quinine. The rapid clearance of plasma TNF in quinine treated patients might be due to the drug's TNF-suppressive activity. FAU - Ittarat, W AU - Ittarat W AD - Department of Clinical Microscopy, Faculty of Medical Technology, Siriraj Hospital, Mahidol University, Bangkok, Thailand. mtwit@mahidol.ac.th FAU - Udomsangpetch, R AU - Udomsangpetch R FAU - Chotivanich, K T AU - Chotivanich KT FAU - Looareesuwan, S AU - Looareesuwan S LA - eng GR - 5 U01 AI35827/AI/NIAID NIH HHS/United States PT - Clinical Trial PT - Comparative Study PT - Controlled Clinical Trial PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, U.S. Gov't, P.H.S. PL - Thailand TA - Southeast Asian J Trop Med Public Health JT - The Southeast Asian journal of tropical medicine and public health JID - 0266303 RN - 0 (Antimalarials) RN - 0 (Artemisinins) RN - 0 (Sesquiterpenes) RN - 0 (Tumor Necrosis Factor-alpha) RN - 60W3249T9M (Artesunate) RN - A7V27PHC7A (Quinine) SB - IM MH - Adult MH - Antimalarials/pharmacology/*therapeutic use MH - *Artemisinins MH - Artesunate MH - Cell Adhesion/drug effects MH - Drug Monitoring/methods MH - Female MH - Humans MH - Infusions, Intravenous MH - Malaria, Falciparum/*blood/*drug therapy/immunology/parasitology MH - Male MH - Middle Aged MH - Quinine/pharmacology/*therapeutic use MH - Sesquiterpenes/pharmacology/*therapeutic use MH - Time Factors MH - Treatment Outcome MH - Tumor Necrosis Factor-alpha/*analysis/*drug effects EDAT- 2000/03/01 09:00 MHDA- 2000/03/11 09:00 CRDT- 2000/03/01 09:00 PHST- 2000/03/01 09:00 [pubmed] PHST- 2000/03/11 09:00 [medline] PHST- 2000/03/01 09:00 [entrez] PST - ppublish SO - Southeast Asian J Trop Med Public Health. 1999 Mar;30(1):7-10.